期刊文献+

七元瓜环纳米腔限制环境下2-(3-乙酰胺基-2-吡啶基)苯并咪唑的激发态质子转移 被引量:3

Investigation of Excited-State Proton Transfer of 2-(3-Acetamido2-pyridyl)benzimidazole in the Confined Nanocavity of Cucurbit[7]uril
原文传递
导出
摘要 以荧光发射光谱,1H NMR谱及量子化学计算研究了2-(3-乙酰胺基-2-吡啶基)苯并咪唑(2-3Am2PyBI)质子转移过程及其与七元瓜环超分子(CB7)的包合作用,考察了乙酰基取代基效应及CB7的包合作用对2-3Am2PyBI质子转移过程的影响.结果表明:乙酰基取代促进了质子转移过程;2-3Am2PyBI阳离子构型更易与CB7发生包合作用;在特定溶液pH值条件下,摩尔比法荧光光谱实验表明超分子包合作用抑制了2-3Am2PyBI的激发态质子转移过程;Benesi-Hildebrand方程拟合得到,超分子体系的包合比为1∶1;1H NMR测试进一步表明2-3Am2PyBI以苯环部分进入CB7的空腔,同时,以量化计算与荧光实验结合,从理论与实验方面共同验证了2-3Am2PyBI的质子转移异构体. The interaction of2-(3-acetamido-2-pyridyl)-benzimidazole (2-3Am2PyBI) with cucurbit[7]uril (CB7) macrocycle and the effect of inclusion on the proton transfer of 2-3Am2PyBI were studied by using emission fluorescence, 1H NMR spec- tra and quantum chemical calculation. By the way, the proton transfer of the dye with and without acetyl (2-3A2PyBI) was also studied. The results indicate that the acetyl promoted the process of proton transfer of the benzimidazole and the cationic form binds with CB7 easier than the other forms of the dye. The fluorescence studying at selected pHs suggest that the proton transfer process of the dye was retarded by interacting with CB7 nanocavity and the molar rate is host vip= 1 : 1 analyzed by the Benesi-Hildebrand method. The dye entered into the CB7 cavity with its benzene ring was proved by the 1H NMR titra- tion experiment and the protonated forms were verified by the quantum calculation with fluorescence spectra.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2013年第7期1451-1456,共6页 Chinese Journal of Organic Chemistry
基金 国家自然科学基金(Nos.21172066 20971041) 湖南省自然科学基金(Nos.10JJ4011 11JJ2007) 湖南省高校科技创新团队支持计划(No [2012]318-17))资助项目~~
关键词 质子转移 七元瓜环 荧光发射光谱 1HNMR谱 量化计算 proton transfer cucurbit[7]uril emission fluorescence 1H NMR spectra quantum calculation
  • 相关文献

参考文献3

二级参考文献50

  • 1汤国庆,尚小明,张桂兰,杜荣建,陈文驹.2-(2'-羟基苯基)苯并噁唑在高分子介质中的激发态分子内质子转移和光谱[J].高等学校化学学报,1996,17(6):906-910. 被引量:1
  • 2严兢,宋寅,彭德高,李珉.芳香性概念的新发展[J].大学化学,2007,22(1):33-40. 被引量:8
  • 3Zhou, X.-X. Curr. Top. Med. Chem. 2006, 6, 851.
  • 4Xiong, X.; Chen, M. S. Antimicrob. Agents Chemother. 1997, 41, 594.
  • 5Balzarini, J.; Herdewijn, P. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 1499.
  • 6Douglash, H. S.; Kevin, T. B.; Sanjay, K. N. Am. J. Physiol. RenalPhysiol. 2001, 281, F 197.
  • 7Hwang, J. T.; Choi, J. R. Drugs Future 2004, 29, 163.
  • 8Fu, X.-Z.; Jiang, S. H.; Li, C. Bioorg. Med. Chem. Lett. 2007, 17, 465.
  • 9Fu, X.-Z.; Jiang, S. H.; Xin, J. Chin. Chem. Lett. 2007, 18, 817.
  • 10Dong, N.; Xue, S. F.; Zhu, Q. J.; Tao, Z.; Zhao, Y.; Yang, L. X. Supramol. Chem. 2008, 20, 663.

共引文献10

同被引文献35

  • 1Shaikh M. , Dutta C. S. , Mohanty J. , Bhasikuttan A. C. , Nau W. M. , Pal H. , Chem. A European J. , 2009, 15(45): 12362- 12370.
  • 2Paul B. K. , Samanta A. , Guchhait N. , Langmuir, 2009, 26(5): 3214-3224.
  • 3Kim C. H. , Joo T. , Phys. Chem. Chem. Phys. , 2009, 11(44): 10266-10269.
  • 4Kwon J. E. , Park S. Y. , Adv. Mater. , 2011, 23(32): 3615-3642.
  • 5Ma Q. , Yang H. , Xu W. C. , Tan Y. B. , Chem. Res. Chinese Universities, 2012, 28(6): 1101-1106.
  • 6Freeman W. A. , Mock W. L. , Shih N. Y. , J. Am. Chem. Soc. , 1981, 103(24): 7367-7368.
  • 7Kim J. , Jung I. , Kim S. , Lee E. , Kang J. , Sakamoto S. , Yamaguchi K. , Kim K. , J. Am. Chem. Soc. , 2000, 122(3): 540-541.
  • 8Walker S. , Oun R. , Mcinnes F .J. , Wheate N. J. , Israel J. Chem. , 2011, 51(56): 616-624.
  • 9Dutta C. S. , Mohanty J. , Upadhyaya H. P. , Bhasikuttan A. C. , Pal H. , J. Phys. Chem. B, 2009, 113(7): 1891-1898.
  • 10Mohanty J. , Bhasikuttan A. C. , Nau W. M. , Pal H. , J. Phys. Chem. B, 2006, 110(I0): 5132-5138.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部